Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Fusion target site

The concept of de-PEGylation can be applied to the development of nanoparticle-based drug delivery systems. PEG is used for the modification of liposomes to increase their blood circulation time [38], However, it also prevents cellular uptake, resulting in a decrease in therapeutic efficiency thus, modifications of the liposome surface with PEG interfere with membrane fusion to the cell membrane and liposome decomposition [39]. One of the possible strategies to solve this problem is to cleave the PEG chains after the nanoparticle reaches the target site (Fig. 9). This system of de-PEGylation of liposomes is also useful in avoiding the immune... [Pg.123]

As an example of purification via the ELP fusion approach Meyer and Chilkoti (Fig. 9, left), purified the proteins thioredoxin and tendamistat. For this purpose these target proteins and ELP were genetically fused via a short peptide sequence that included a thrombin cleavage site, which allows the removal of the ELP tag after the purification is completed. The general outline of the purification procedure... [Pg.81]

Fig. 4.1. Fundamentals of the ubiquitin system. Adapted from Ref [5]. Figure 4.1 shows the fundamentals of the ubiquitin system. (1) Ubiquitin is synthesized in linear chains or as the N-terminal fusion with small ribosomal subunits that are cleaved by de-ubiquitylating enzymes to form the active protein. Ubiquitin is then activated in an ATP-dependent manner by El where a thiolester linkage is formed. It is then transthiolated to the active-site cysteine of an E2. E2s interact with E3s and with substrates and mediate either the indirect (in the case of HECT E3s) or direct transfer of ubiquitin to substrate. A number of factors can affect this process. We know that interactions with Hsp70 can facilitate ubiquitylation in specific instances and competition for lysines on substrates with the processes of acetylation and sumoylation may be inhibitory in certain instances. (2) For efficient proteasomal targeting to occur chains of ubiquitin linked internally through K48 must be formed. This appears to involve multiple... Fig. 4.1. Fundamentals of the ubiquitin system. Adapted from Ref [5]. Figure 4.1 shows the fundamentals of the ubiquitin system. (1) Ubiquitin is synthesized in linear chains or as the N-terminal fusion with small ribosomal subunits that are cleaved by de-ubiquitylating enzymes to form the active protein. Ubiquitin is then activated in an ATP-dependent manner by El where a thiolester linkage is formed. It is then transthiolated to the active-site cysteine of an E2. E2s interact with E3s and with substrates and mediate either the indirect (in the case of HECT E3s) or direct transfer of ubiquitin to substrate. A number of factors can affect this process. We know that interactions with Hsp70 can facilitate ubiquitylation in specific instances and competition for lysines on substrates with the processes of acetylation and sumoylation may be inhibitory in certain instances. (2) For efficient proteasomal targeting to occur chains of ubiquitin linked internally through K48 must be formed. This appears to involve multiple...

See other pages where Fusion target site is mentioned: [Pg.568]    [Pg.143]    [Pg.284]    [Pg.49]    [Pg.339]    [Pg.142]    [Pg.367]    [Pg.366]    [Pg.783]    [Pg.113]    [Pg.490]    [Pg.581]    [Pg.113]    [Pg.581]    [Pg.455]    [Pg.200]    [Pg.489]    [Pg.1030]    [Pg.1251]    [Pg.5]    [Pg.180]    [Pg.180]    [Pg.198]    [Pg.269]    [Pg.81]    [Pg.82]    [Pg.8]    [Pg.74]    [Pg.268]    [Pg.313]    [Pg.329]    [Pg.176]    [Pg.425]    [Pg.81]    [Pg.81]    [Pg.140]    [Pg.158]    [Pg.145]    [Pg.13]    [Pg.393]    [Pg.320]    [Pg.602]    [Pg.16]    [Pg.362]    [Pg.206]   
See also in sourсe #XX -- [ Pg.284 ]




SEARCH



Target sites

© 2024 chempedia.info